World Medical
This article was originally published in The Gray Sheet
Executive Summary
First implant of the firm's Talent LoPro endoluminal stent graft system for minimally invasive repair of abdominal aortic aneurysm (AAA) is performed May 22 at the Montreal Heart Institute. The LoPro "features a 2 to 4 Fr lower profile introduction system compared to the original" Talent AAA system, U.S. clinical trials for which are scheduled for completion this fall. Arterial Vascular Engineering reported April 13 a stock-swap deal to purchase World Medical for $62 mil.; the deal is scheduled to close by July ("The Gray Sheet" April 20, p. 7)